M4MM
DPA Petition Urges Trump to Fully Deschedule Cannabis Amid Rescheduling Discussions
LOS ANGELES – The Drug Policy Alliance (DPA) has launched a petition urging the Trump administration to remove Cannabis from the Controlled Substances Act (CSA), arguing that a proposed shift to Schedule III fails to ...
Ibogaine Gains Spotlight as Former House Speaker Calls for Wider Access
WASHINGTON, D.C. – Newt Gingrich, a Former House Speaker, has drawn attention to ibogaine, a psychedelic compound derived from the African iboga shrub, calling it a potential game-changer for treating addiction, post-traumatic stress disorder (PTSD), ...
Colombian President Pushing Congress for Swift Action on Full Cannabis Legalization
BOGOTÁ – Colombia's House of Representatives First Committee has passed a bill to legalize adult-use Cannabis, marking an early win for reformers in a country long at the center of global drug policy debates. Sponsored ...
Organigram Global Launches Collective Project THC Beverages in 25 U.S. States
TORONTO – Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), Canada’s leading cannabis company by market share, has made a significant stride into the U.S. market with the launch of its hemp-derived THC beverage brand, Collective ...
Brazilian App Turns Patient Adoption Into a Cannabis Data Asset
LOS ANGELES- Brazil’s health-tech startup Blis says its mobile platform now supports more than 300,000 registered patients, generates roughly R$2 million (about US$363,000) in monthly revenue and reaches users in more than 1,800 municipalities. By ...
Blüm Holdings to Acquire Northern California Cannabis Dispensary
LOS ANGELES- Blüm Holdings Inc, a California-based publicly traded holding company and cannabis operator, has signed a binding all‑stock agreement to acquire a majority stake in a licensed adult‑use and medical cannabis dispensary in Northern ...
Colorado Legal Cannabis Market Sees Sustained Growth Through 2030
LOS ANGELES- A recent industry report estimates that Colorado’s legal cannabis market, valued at approximately USD 2.59 billion in 2024, is projected to expand at a compound annual growth rate (CAGR) of 12.9% between 2025 and 2030—reaching ...
DPA Petition Urges Trump to Fully Deschedule Cannabis Amid Rescheduling Discussions
LOS ANGELES – The Drug Policy Alliance (DPA) has launched a petition urging the Trump administration to remove Cannabis from the Controlled Substances Act (CSA), arguing that a proposed shift to Schedule III fails to ...
Ibogaine Gains Spotlight as Former House Speaker Calls for Wider Access
WASHINGTON, D.C. – Newt Gingrich, a Former House Speaker, has drawn attention to ibogaine, a psychedelic compound derived from the African iboga shrub, calling it a potential game-changer for treating addiction, post-traumatic stress disorder (PTSD), ...
Colombian President Pushing Congress for Swift Action on Full Cannabis Legalization
BOGOTÁ – Colombia's House of Representatives First Committee has passed a bill to legalize adult-use Cannabis, marking an early win for reformers in a country long at the center of global drug policy debates. Sponsored ...
California to Implement New Employment Protections for Cannabis Users in 2024
LOS ANGELES- California is set to enact groundbreaking laws that provide new protections for employees who consume cannabis, marking a significant shift in workplace policies since the state's major cannabis reforms. Starting January 1, 2024, ...
Organigram Reports Q3 Fiscal 2023
LOS ANGELES- Organigram Holdings Inc. a licensed producer of cannabis, today unveiled its financial outcomes for the third quarter ending May 31, 2023. The period was marked by remarkable resilience and growth in the company’s ...
Nebraska Medical Cannabis Initiative Gains Momentum Amid Opposition
LOS ANGELES- In Nebraska, a significant movement is underway as the group Nebraskans for Medical Marijuana (NMM) intensifies its efforts to gather signatures for two pivotal medical cannabis legalization initiatives aimed for the 2024 ballot. ...
MindMed Announces Promising Results from Phase 2b Trial of MM-120 for Generalized Anxiety Disorder
LOS ANGELES- Mind Medicine (MindMed) Inc, a biotech company focusing on psychedelic-inspired therapies, recently revealed encouraging topline results from its Phase 2b clinical trial of MM-120 (lysergide d-tartrate) in treating Generalized Anxiety Disorder (GAD). The ...
Sunstone Therapies Reports Breakthrough in Psilocybin-Assisted Therapy for Cancer Patients with Depression
LOS ANGELES- Sunstone Therapies, a organization in psychedelic-assisted therapy, recently announced notable findings from its phase 2 clinical trial, published in the journal Cancer. This trial marks a significant step in understanding the potential of ...
CSU’s Institute of Cannabis Research Invests $800,000 in Groundbreaking Studies
LOS ANGELES- The Institute of Cannabis Research (ICR) at Colorado State University (CSU), Pueblo, has announced a significant investment in cannabis research, earmarking $800,000 for six pioneering studies. This initiative, funded through the Colorado Marijuana ...
Federal Cannabis Legalization: A Path to $8.5 Billion in Tax Revenue
LOS ANGELES- In a groundbreaking analysis, the Tax Foundation, a Washington D.C.-based think tank renowned for its insights on taxation, has released a report that casts new light on the potential fiscal benefits of federal ...
Clearmind Medicine Inc. Regains Nasdaq Compliance with Enhanced Bid Price Stability
LOS ANGELES- Clearmind Medicine Inc. has recently achieved a significant financial milestone. The biotech company, known for its innovative approach in developing psychedelic-derived therapeutics, announced its regained compliance with Nasdaq's minimum bid price requirement. This ...
Colorado’s MED Prepares for Future of Cannabis Inventory Tracking
LOS ANGELES- The Colorado Marijuana Enforcement Division (MED) is at a pivotal juncture in its oversight of the state's cannabis industry. Since the legalization of recreational cannabis in 2012, the MED has played a crucial ...
Massachusetts Cannabis Control Commission Officials’ Suspension
LOS ANGELES- In a recent development that has sent ripples through Massachusetts' cannabis sector, the Massachusetts Cannabis Control Commission is grappling with internal instability following the suspension of two senior executives. This turmoil, underscoring potential ...
Algernon Pharmaceuticals Announces $150,000 Private Placement for Working Capital
LOS ANGELES- Algernon Pharmaceuticals Inc., a Canadian clinical stage pharmaceutical development company, has announced a non-brokered private placement aiming to raise $150,000. The offering comprises units priced at $0.075 each, with each unit consisting of ...
MindMed Announces Breakthrough in GAD Treatment with MM-120 in Clinical Trial
LOS ANGELES- Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, has reported promising results from its Phase 2b clinical trial of MM-120 (lysergide d-tartrate) in treating generalized anxiety disorder (GAD). The trial achieved its ...
Trulieve Alabama Recognized as Minority-Owned Business
LOS ANGELES- The Alabama Medical Cannabis Commission (AMCC) has recently taken a significant step forward in the development of the state's medical cannabis industry. In a pivotal move, the AMCC awarded integrated licenses to five ...
Cannabis Bioscience International Holdings (CBIH) Announces SEC Approval for Common Stock Sale
LOS ANGELES- Cannabis Bioscience International Holdings (CBIH), a prominent player in the cannabis bioscience sector, announced on Friday a significant milestone in its financial journey. The company's registration statement on Form S-1, under the Securities ...
Beckley Academy Strengthens Psychedelic Therapy Training Team with New Facilitators
LOS ANGELES- Beckley Academy, a prominent training organization specializing in the preparation of mental health professionals for psychedelic therapies, has announced the addition of two new facilitators to their team, Sara Gael Beauregard and Mary ...
